11 Myths About Bioidentical Hormones That Compounding Pharmacies and Functional Medicine Clinics Are Still Spreading in 2025
When the hot flashes started, the first thing someone told me was to look into bioidentical hormones — 'they're natural, they're safe, they're nothing like the synthetic stuff.' It took a long time to untangle the marketing from the medicine, and honestly, some of what I found made me angry on behalf of every woman who paid hundreds of dollars for an unregulated cream. You deserve the full picture, not a sales pitch dressed up as wellness.
Learn more about Rose →Myth: 'Bioidentical' is a medical or regulatory term that means something specific
The word bioidentical has no definition in any regulatory framework — not the FDA, not the EMA, not any national medicines agency. It was coined and popularised largely by compounding pharmacies and integrative practitioners to differentiate their products from regulated HRT, but it carries no legal or clinical meaning. Any hormone product can be called bioidentical by anyone, with no verification required.
Myth: Bioidentical hormones are not hormones — they're natural
Estradiol is estradiol, progesterone is progesterone — whether derived from a yam, synthesised in a lab, or manufactured by a pharmaceutical company. The molecular structure of a bioidentical hormone is identical to that of its regulated pharmaceutical equivalent, which means the body processes them the same way and they carry the same physiological effects and risks. Calling them 'natural' exploits a gap between how that word is understood by consumers and what it means biologically.
Myth: Compounded bioidentical hormones are safer than regulated HRT
Compounded preparations are not subject to the same manufacturing standards, potency testing, sterility checks, or post-market surveillance as regulated pharmaceutical products. Studies examining compounded hormone preparations have found significant variability in actual hormone content — some delivering far more or far less than the stated dose. This inconsistency is not a minor quality-control footnote; it has real clinical consequences for both efficacy and safety.
Myth: Bioidentical progesterone carries no breast cancer risk because it's 'the same as your own'
The claim that bioidentical progesterone is breast-safe while synthetic progestogens are not is based on a selective reading of the evidence, most notably the French E3N cohort study. Subsequent research, including large observational data and the CECILE study, has found that micronised progesterone — the most commonly used bioidentical form — is associated with increased breast cancer risk with prolonged use, even if the magnitude may differ from some synthetic progestogens. No form of progesterone has been demonstrated to be entirely breast-risk-neutral over the long term.
Myth: Saliva testing is the gold standard for measuring hormone levels in women using bioidentical HRT
Saliva hormone testing is widely promoted by compounding clinics as a more accurate reflection of 'free' hormone levels than blood serum testing, but this claim is not supported by clinical evidence. Results from saliva testing are highly variable depending on time of day, hydration, food intake, and collection technique, and reference ranges have not been validated for menopausal women. Major endocrinology bodies do not recommend saliva testing for guiding HRT dosing decisions.
Myth: Bespoke compounded formulas are more effective because they're tailored to the individual
The idea that a custom-compounded hormone blend is more precisely matched to a woman's needs sounds intuitively appealing, but it assumes that the dose delivered matches the dose compounded — an assumption the evidence does not support. Regulated HRT already comes in a wide range of doses, delivery methods, and formulations that cover the needs of the vast majority of women. The 'tailored' framing is more a marketing differentiator than a clinical advantage, and the inconsistency of compounded preparations may actually make precise dosing harder, not easier.
Myth: Bioidentical testosterone pellets are a well-evidenced, safe method of testosterone delivery
Testosterone pellet implants — inserted subcutaneously and releasing hormone over several months — are aggressively marketed at compounding clinics as a superior method for addressing low libido and fatigue in perimenopausal women. However, pellets deliver supraphysiological testosterone levels in many patients, and because they cannot be removed once inserted, any adverse effects must simply be waited out. Testosterone pellets are not approved by the FDA or other major regulatory bodies for use in women, and the evidence base for their safety and efficacy is significantly weaker than that for regulated testosterone preparations.
Myth: If it's prescribed by a doctor, compounded bioidentical HRT must have been properly tested
A prescription from a licensed physician does not mean a compounded preparation has undergone clinical trials, safety testing, or quality verification equivalent to a regulated medicine. Doctors can legally prescribe compounded preparations, but in doing so they are working outside the evidence base that governs regulated pharmaceuticals. The prescriber's willingness to prescribe is not a proxy for the product's safety profile.
Myth: Bioidentical HRT does not carry the cardiovascular risks associated with conventional HRT
There is no robust clinical evidence demonstrating that compounded bioidentical hormones carry a meaningfully different cardiovascular risk profile from regulated HRT containing equivalent molecules. The cardiovascular risks associated with HRT are primarily related to the type of progestogen, the route of estrogen delivery, and the timing of initiation relative to menopause — none of which are altered simply because the source is a compounding pharmacy. Claims to the contrary are not supported by randomised controlled trial data.
Myth: Estriol — often featured in compounded creams — is a safer estrogen because it's weaker
Estriol is frequently promoted in compounded preparations as a gentler, safer estrogen because it has lower potency at classical estrogen receptors than estradiol. However, estriol's lower potency means it may also provide less protection against osteoporosis and less effective symptom relief, and it is not approved for systemic use in most countries because its long-term safety data are far thinner than those for estradiol. The framing of 'weaker equals safer' is a simplification that omits important clinical trade-offs.
Myth: Women whose doctors dismiss bioidentical hormones are just encountering mainstream medicine's resistance to natural solutions
When a GP or gynaecologist recommends regulated HRT over compounded bioidentical preparations, it is not because they are dismissing 'natural' approaches or are uninformed about alternatives — it is because the evidence base supports regulated products and does not support unregulated compounded ones. Framing clinical scepticism as closed-mindedness is a rhetorical move that positions compounding clinics as maverick truth-tellers and discourages women from asking legitimate questions about what they are actually being sold. Women deserve practitioners who follow the evidence, and they deserve to know when the evidence is absent.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.